94 related articles for article (PubMed ID: 18230077)
1. CYP2D6 genotyping and codeine.
de Leon J
Paediatr Anaesth; 2008 Mar; 18(3):274-5; author reply 275-6. PubMed ID: 18230077
[No Abstract] [Full Text] [Related]
2. Children's deaths linked with postsurgical codeine.
Voelker R
JAMA; 2012 Sep; 308(10):963. PubMed ID: 22968872
[No Abstract] [Full Text] [Related]
3. Re: Apnea in a child after oral codeine: a genetic variant - an ultra-rapid metabolizer [corrected].
de Wildt SN; Koren G
Paediatr Anaesth; 2008 Mar; 18(3):273-4; author's reply 275-6. PubMed ID: 18230076
[No Abstract] [Full Text] [Related]
4. Apnea in a child after oral codeine: a genetic variant - an ultra-rapid metabolizer.
Voronov P; Przybylo HJ; Jagannathan N
Paediatr Anaesth; 2007 Jul; 17(7):684-7. PubMed ID: 17564651
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetics of neonatal opioid toxicity following maternal use of codeine during breastfeeding: a case-control study.
Madadi P; Ross CJ; Hayden MR; Carleton BC; Gaedigk A; Leeder JS; Koren G
Clin Pharmacol Ther; 2009 Jan; 85(1):31-5. PubMed ID: 18719619
[TBL] [Abstract][Full Text] [Related]
6. Genes and the response to drugs.
Caraco Y
N Engl J Med; 2004 Dec; 351(27):2867-9. PubMed ID: 15625340
[No Abstract] [Full Text] [Related]
7. Suspected opioid overdose case resolved by CYP2D6 genotyping.
Shaw KD; Amstutz U; Jimenez-Mendez R; Ross CJ; Carleton BC
Ther Drug Monit; 2012 Apr; 34(2):121-3. PubMed ID: 22406651
[TBL] [Abstract][Full Text] [Related]
8. Response to hydrocodone, codeine and oxycodone in a CYP2D6 poor metabolizer.
Susce MT; Murray-Carmichael E; de Leon J
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1356-8. PubMed ID: 16631290
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of cytochrome P450 2D6 modifies codeine abuse liability.
Kathiramalainathan K; Kaplan HL; Romach MK; Busto UE; Li NY; Säwe J; Tyndale RF; Sellers EM
J Clin Psychopharmacol; 2000 Aug; 20(4):435-44. PubMed ID: 10917405
[TBL] [Abstract][Full Text] [Related]
10. New evidence about an old drug--risk with codeine after adenotonsillectomy.
Racoosin JA; Roberson DW; Pacanowski MA; Nielsen DR
N Engl J Med; 2013 Jun; 368(23):2155-7. PubMed ID: 23614474
[No Abstract] [Full Text] [Related]
11. Codeine, ultrarapid-metabolism genotype, and postoperative death.
Ciszkowski C; Madadi P; Phillips MS; Lauwers AE; Koren G
N Engl J Med; 2009 Aug; 361(8):827-8. PubMed ID: 19692698
[No Abstract] [Full Text] [Related]
12. The potential role of the cytochrome P-450 2D6 pharmacogenetic polymorphism in drug abuse.
Sellers EM; Otton SV; Tyndale RF
NIDA Res Monogr; 1997; 173():6-26. PubMed ID: 9260180
[No Abstract] [Full Text] [Related]
13. Codeine induced respiratory depression in a child.
Stamer UM; Stüber F
Paediatr Anaesth; 2008 Mar; 18(3):272-3; author reply 275-6. PubMed ID: 18230075
[No Abstract] [Full Text] [Related]
14. The efficacy of simvastatin is not influenced by CYP2D6 polymorphism.
Geisel J; Kivistö KT; Griese EU; Eichelbaum M
Clin Pharmacol Ther; 2002 Nov; 72(5):595-6. PubMed ID: 12426523
[No Abstract] [Full Text] [Related]
15. Codeine Ultra-rapid Metabolizers: Age Appears to be a Key Factor in Adverse Effects of Codeine.
Heintze K; Fuchs W
Drug Res (Stuttg); 2015 Dec; 65(12):640-4. PubMed ID: 25585351
[TBL] [Abstract][Full Text] [Related]
16. Rapid and reliable genotyping procedure for detection of alleles with mutations, deletion, or/and duplication of the CYP2D6 gene.
Arneth B; Shams M; Hiemke C; Härtter S
Clin Biochem; 2009 Aug; 42(12):1282-90. PubMed ID: 19393232
[TBL] [Abstract][Full Text] [Related]
17. A software tool to adjust codeine dose based on CYP2D6 gene-pair polymorphisms and drug-drug interactions.
Saab Y; Nakad Z
Pharmacogenomics J; 2023 Nov; 23(6):217-224. PubMed ID: 37940650
[TBL] [Abstract][Full Text] [Related]
18. Clinical practice guideline: CYP2D6 genotyping for safe and efficacious codeine therapy.
Madadi P; Amstutz U; Rieder M; Ito S; Fung V; Hwang S; Turgeon J; Michaud V; Koren G; Carleton BC;
J Popul Ther Clin Pharmacol; 2013; 20(3):e369-96. PubMed ID: 24214521
[TBL] [Abstract][Full Text] [Related]
19. Can extremely low or high morphine formation from codeine be predicted prior to therapy initiation?
Lötsch J; Rohrbacher M; Schmidt H; Doehring A; Brockmöller J; Geisslinger G
Pain; 2009 Jul; 144(1-2):119-24. PubMed ID: 19395173
[TBL] [Abstract][Full Text] [Related]
20. The AmpliChip CYP450 test: cytochrome P450 2D6 genotype assessment and phenotype prediction.
Rebsamen MC; Desmeules J; Daali Y; Chiappe A; Diemand A; Rey C; Chabert J; Dayer P; Hochstrasser D; Rossier MF
Pharmacogenomics J; 2009 Feb; 9(1):34-41. PubMed ID: 18591960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
